Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Zydus Lifesciences Limited
Press Release Jan 28 2021
Published Jan 28 2021
3 min read

Press Release Jan 28 2021

Cadila Healthcare Limited has informed the Exchange regarding a press release dated January 28, 2021, titled "Zydus granted Orphan Drug Designation by the USFDA for Saroglitazar in the treatment of patients with Primary Biliary Cholangitis (PBC)".

View Attachment